Keywords: bayer, examines, glucobay, cv, prevention, germany, healthcare

Bayer examines Glucobay in CV prevention

Article | 30 April 2007

Print This

Germany's Bayer HealthCare AG, part of the Bayer group, says that it has initiated a trial designed to examine its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in